Barrett J E, Dawson G, Heller J, Bairstow C, Fico R, Webber J S, Gutierrez R, Decker R H
Am J Clin Pathol. 1986 Aug;86(2):180-5. doi: 10.1093/ajcp/86.2.180.
An enzyme immunoassay (EIA), designed to detect antibodies to human T-cell lymphotropic virus type III (HTLV III), was evaluated. The antibody test was found to be highly sensitive; serum from 221 of 223 (99.1%) patients with acquired immune deficiency syndrome (AIDS) was positive for antibodies to HTLV III. In addition, the antibody test was found to be highly specific; approximately 99.75% of 20,720 serum or plasma samples from blood donors were negative for antibody to HTLV III. In most cases, the Western Blot analysis agreed well with the EIA. Eighty-one of 82 (98.8%) EIA-positive samples from patients with AIDS were Western Blot positive. Of the EIA-positive blood donors, 21 of 36 (58%) were detected and confirmed by Western Blot analysis. A solid-phase competitive EIA also was evaluated as an alternate procedure. The preliminary results indicate that this immunoassay has a high degree of sensitivity and specificity and could serve as an alternate procedure to detect antibody to HTLV III.
对一种旨在检测抗人类III型嗜T细胞病毒(HTLV III)抗体的酶免疫测定法(EIA)进行了评估。发现该抗体检测具有高度敏感性;223例获得性免疫缺陷综合征(AIDS)患者中有221例(99.1%)的血清抗HTLV III抗体呈阳性。此外,还发现该抗体检测具有高度特异性;20720份来自献血者的血清或血浆样本中约99.75%抗HTLV III抗体呈阴性。在大多数情况下,蛋白质印迹分析与EIA结果高度一致。82例AIDS患者的EIA阳性样本中有81例(98.8%)蛋白质印迹呈阳性。在EIA阳性的献血者中,36例中有21例(58%)经蛋白质印迹分析检测并确认。还对一种固相竞争性EIA作为替代方法进行了评估。初步结果表明,这种免疫测定法具有高度的敏感性和特异性,可作为检测抗HTLV III抗体的替代方法。